Preliminary study of bone marrow derived mesenchymal stem cell transplantation for primary biliary cirrhosis of animal models

王丹丹,张华勇,顾志峰,马晓蕾,黄静,林静,孙凌云

DOI: https://doi.org/10.3760/cma.j.issn.1007-7480.2009.11.013

2009-01-01

Abstract:Objective To investigate the therapeutic effect of bone marrow mesenchmal stem cell(BM-MSC) transplantation for primary biliary cirrhosis (PBC) in animal models induced by polyinosinic polycytidylic acid(Poly I:C). Methods Twenty three 4-6 week old C57BL/6 mice were divided into two groups as following: mice in model group were injected with Poly I:C intraperitoneally two times per week, and the control group were treated with PBS instead.PBC animal models wen established 16 weeks after the injection. Then the mice in the PBC models were divided into BM-MSC-treated group and no BM-MSC group, all mice were sacrificed 6 weeks later in order to test the therapeutic effect of BM-MSC. Results ①Sixteen weeks after Poly I:C injection, mice in the model group had much higher level of ALP than the control group (P<0.05), ALT level was also increased, and the positive rate of AMA and ANA was elevated at different extent. Infiltration of mononuclear cells was observed in the portal area in the livers of the model group. ②After 6 weeks of BM-MSC injection, ALP levels'decreased significantly [(112±16) U/L vs (135±16) U/L, P=0.01]. ALT level was also decreased, but with no significant difference(PM).05). ③ The titer of AMA and ANA in BM-MSC-treated group was much lower than that of the no BM-MSC group after 6 weeks (P<0.05).④BM-MSC treatment could ameliorate the histological changes of liver in PBC mice. Conclusion Animal models of PBC can be established by injection of Poly I:C. BM-MSC transplantation has therapeutic effect on PBC animal models.